Literature DB >> 30765474

Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma.

Christos Sachpekidis1,2, Maximilian Merz2,3, Annette Kopp-Schneider4, Anna Jauch5, Marc-Steffen Raab2, Sandra Sauer2, Jens Hillengass6, Hartmut Goldschmidt2,3, Antonia Dimitrakopoulou-Strauss7.   

Abstract

Entities:  

Year:  2019        PMID： 30765474      PMCID： PMC6717572          DOI： 10.3324/haematol.2018.213041

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.

Authors:  Kai Neben; Henk M Lokhorst; Anna Jauch; Uta Bertsch; Thomas Hielscher; Bronno van der Holt; Hans Salwender; Igor W Blau; Katja Weisel; Michael Pfreundschuh; Christof Scheid; Ulrich Dührsen; Walter Lindemann; Ingo G H Schmidt-Wolf; Norma Peter; Christian Teschendorf; Hans Martin; Mathias Haenel; Hans G Derigs; Marc S Raab; Anthony D Ho; Helgi van de Velde; Dirk Hose; Pieter Sonneveld; Hartmut Goldschmidt
Journal:  Blood       Date:  2011-12-08       Impact factor: 22.113

2.  Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma.

Authors:  Rauf Haznedar; Sahika Z Akı; Ozgür U Akdemir; Zübeyde N Ozkurt; Ozcan Ceneli; Münci Yağcı; Gulsan T Sucak; Mustafa Unlü
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-02       Impact factor: 9.236

Review 3.  Multiple myeloma: disease response assessment.

Authors:  E Zamagni; P Tacchetti; C Terragna; M Cavo
Journal:  Expert Rev Hematol       Date:  2016-07-25       Impact factor: 2.929

4.  (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.

Authors:  Christos Sachpekidis; Elias K Mai; Hartmut Goldschmidt; Jens Hillengass; Dirk Hose; Leyun Pan; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Clin Nucl Med       Date:  2015-06       Impact factor: 7.794

Review 5.  Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

Authors:  Michele Cavo; Evangelos Terpos; Cristina Nanni; Philippe Moreau; Suzanne Lentzsch; Sonja Zweegman; Jens Hillengass; Monika Engelhardt; Saad Z Usmani; David H Vesole; Jesus San-Miguel; Shaji K Kumar; Paul G Richardson; Joseph R Mikhael; Fernando Leal da Costa; Meletios-Athanassios Dimopoulos; Chiara Zingaretti; Niels Abildgaard; Hartmut Goldschmidt; Robert Z Orlowski; Wee Joo Chng; Hermann Einsele; Sagar Lonial; Bart Barlogie; Kenneth C Anderson; S Vincent Rajkumar; Brian G M Durie; Elena Zamagni
Journal:  Lancet Oncol       Date:  2017-04       Impact factor: 41.316

6.  Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

Authors:  Elena Zamagni; Francesca Patriarca; Cristina Nanni; Beatrice Zannetti; Emanuela Englaro; Annalisa Pezzi; Paola Tacchetti; Silvia Buttignol; Giulia Perrone; Annamaria Brioli; Lucia Pantani; Carolina Terragna; Francesca Carobolante; Michele Baccarani; Renato Fanin; Stefano Fanti; Michele Cavo
Journal:  Blood       Date:  2011-09-06       Impact factor: 22.113

7.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

8.  Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation.

Authors:  Christos Sachpekidis; J Hillengass; H Goldschmidt; B Wagner; U Haberkorn; K Kopka; A Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-29       Impact factor: 9.236

9.  F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Authors:  Twyla B Bartel; Jeff Haessler; Tracy L Y Brown; John D Shaughnessy; Frits van Rhee; Elias Anaissie; Terri Alpe; Edgardo Angtuaco; Ronald Walker; Joshua Epstein; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

10.  Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.

Authors:  Sree Harsha Tirumani; Christopher Sakellis; Heather Jacene; Atul B Shinagare; Nikhil C Munshi; Nikhil H Ramaiya; Annick D Van den Abbeele
Journal:  Clin Nucl Med       Date:  2016-01       Impact factor: 7.794
View more
  5 in total

1.  Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at diagnosis in untreated multiple myeloma patients: a systematic review and meta-analysis.

Authors:  Qian Li; Linhui Hu; Alice Charwudzi; Weiwei Zhu; Ye Meng; Zhimin Zhai
Journal:  Clin Exp Med       Date:  2022-01-09       Impact factor: 3.984

Review 2.  [Positron emission tomography/computed tomography (PET/CT) in multiple myeloma].

Authors:  Christos Sachpekidis; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Radiologe       Date:  2021-12-17       Impact factor: 0.635

3.  Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in newly diagnosed multiple myeloma: a systematic review and meta-analysis.

Authors:  Sangwon Han; Sungmin Woo; Yong-Il Kim; Dok Hyun Yoon; Jin-Sook Ryu
Journal:  Eur Radiol       Date:  2020-08-18       Impact factor: 5.315

4.  Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?

Authors:  Christos Sachpekidis; Annette Kopp-Schneider; Maximilian Merz; Anna Jauch; Marc-Steffen Raab; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

Review 5.  Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.

Authors:  Christos Sachpekidis; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Molecules       Date:  2019-12-29       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.